Board of Directors & Board committees

 

Michael Wolff Jensen

Chairman

Board member as well as chairman since 2013
Chairman of the Remuneration Committee
Born 1971

Education: Master of Laws (LL.M.), University of Copenhagen

Other current activities: Other current activities: Chairman of the Board in Ascendis Pharma A/S, Vicore Pharma AB and VISEN Pharmaceuticals Ltd, Chairman of the Board as well as owner of MIWO Invest ApS (former MWJ Partners ApS), board member of Xspray Pharma Futurum AB

Other board assignments (the recent 5 years): Chairman of the Board in Eurocines Vaccines AB and VANX ApS

Holdings: 25,000 shares through MIWO Invest ApS (former MWJ Partners ApS)

Independent in relation to the Company and its management and in relation to major shareholders

Maris Hartmanis

Board member

Board member since 2015
Chairman of the Audit Committee
Born 1953

Education: Dr. of Technology and Associate Professor, Royal Institute of Technology

Other current activities: Other current activities: CEO and Chairman of the Board in Hartmanis & Partners AB as well as board member in BioLamina, CEO and Chairman of the foundation FINGERS Brain Health Institute

Other board assignments (the recent 5 years): Board member in Xbrane Biopharma AB, karolinska Institutet Holding AB and Applied Photophysics Ltd., England, and vice Chairman of the Board in ProNova, a VINNOVA Center of Excellence for protein technology at Kungliga Tekniska Högskolan

Holdings: 28,619 shares

Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak

Board member

Board member since 2015
Member of the Audit Committee
Born 1956

Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet

Other current activities: Other current assignment: Board member of Atrogi AB, Empros Pharma AB, Follicum AB, Inject Pharma Sweden AB, KAHR Medical Ltd., Pharmacolog in Uppsala AB (publ), Prokarium Ltd., SwedenBIO Service AB, Binx Helth Ltd, UK and Symcel AB, member of board as well as CEO of Recipharm Venture Fund AB and deputy in Buzzard Pharmaceuticals AB

Other board assignments (the recent 5 years): Chairman of the board in Bostadsrättsföreningen Smultronhyllan, Cobra Biologics Matfors AB, Cobra Biopharma Matfors AB, Cobra Biologics Holding AB,
Recipharm OT Chemistry AB and Recipharm Pharmaceutical Development AB. Member of the board in Synthonics, Inc., Pharmanest
AB, Recipharm OT Chemistry AB och Recipharm Strängnäs AB and deputy member of the board in Cobra Biologics AB och Cormorant
Pharmaceuticals AB

Holdings: None

Independent in relation to the Company and its management and in relation to major shareholders

Torbjörn Koivisto

Board member

Board member since 2017
Member of the Remuneration Committee
Born 1969

Education: Master of Laws (LL.M.), University of Uppsala

Other current activities: Other current activities: Board member of Hemcheck Sweden AB, Cinclus Pharma Holding AB and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, partner in KOL Arts & Craft Handelsbolag as well as deputy of RJC Roger Johansson Consulting AB

Holdings: 4,000 shares via company (IARU)

Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind

Board member

Board member since 2019
Member of the Audit Committee
Born 1974

Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

Other current activities: Other current activities: Chairman and CEO of Lind Growth Strategy AB, member of the board in Immunicum AB and deputy board member of Shinka Life Sciences AB

Other board assignments (the recent 5 years): CEO of Medivir AB

Holdings: 4,000 shares

Independent in relation to the Company and its management and in relation to major shareholders

Gunnar Gårdemyr

Board member

Board member since 2019
Member of the Remuneration Committee
Born 1959

Education: BSc Economy, University of Lund

Other current activities: Other current assignments: Chairman of the Board in Rhovac AB, member of the Board in Iconovo AB and Asgard Therapeutics

Other board assignments (the recent 5 years): CEO Targovax AS, Norge, CBO in Follicum AB

Holdings: 4,400 shares

Independent in relation to the Company and its management and in relation to major shareholders

Board committees

Audit Committee

  • Maris Hartmanis, Chairman
  • Christine Lind
  • Carl-Johan Spak

Renumeration committee

  • Michael Wolff Jensen, Chairman
  • Gunnar Gårdemyr
  • Torbjörn Koivisto